Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of ghrelin and unacylated ghrelin compositions for treating insulin resistance

Use of ghrelin and unacylated ghrelin compositions for treating insulin resistance

US Patent 7825090 · Granted Nov 2, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylat2017
Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in 2013
Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity2012
Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders2012
Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders2012
Methods for promoting growth and survival of insulin-secreting cells2011
Methods for promoting growth and survival of insulin-secreting cells2011
Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses2010
Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses2009
Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses2009
Treatment of tumors by administration of growth hormone releasing compounds and 2000
Pharmaceutical composition for intranasal administration, comprising GH-releasin1991